For: | Matiollo C, Rateke ECM, Moura EQA, Andrigueti M, Augustinho FC, Zocche TL, Silva TE, Gomes LO, Farias MR, Narciso-Schiavon JL, Schiavon LL. Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis. World J Hepatol 2022; 14(11): 1964-1976 [PMID: 36483607 DOI: 10.4254/wjh.v14.i11.1964] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v14/i11/1964.htm |
Number | Citing Articles |
1 |
Anuraag Jena, Vishal Sharma, Usha Dutta. Fecal calprotectin in cirrhosis—Does “ESR” of the intestine measure the liver dysfunction too?. Indian Journal of Gastroenterology 2023; 42(6): 754 doi: 10.1007/s12664-023-01481-2
|
2 |
Martí Ortega-Ribera, Yuan Zhuang, Veronika Brezani, Prashanth Thevkar Nagesh, Radhika S. Joshi, Mrigya Babuta, Yanbo Wang, Gyongyi Szabo. G-CSF increases calprotectin expression, liver damage and neuroinflammation in a murine model of alcohol-induced ACLF. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1347395
|
3 |
Marta Fortuny, Maria‐Rosa Sarrias, Maria Torner, Ignacio Iborra, Ariadna Clos, Alba Ardèvol, Ramon Bartolí, Rosa M. Morillas, Eugeni Domènech, Helena Masnou. Systematic review of the role of calprotectin in cirrhosis. European Journal of Clinical Investigation 2024; 54(2) doi: 10.1111/eci.14111
|
4 |
Irina Balazs, Vanessa Stadlbauer. Circulating neutrophil anti-pathogen dysfunction in cirrhosis. JHEP Reports 2023; 5(11): 100871 doi: 10.1016/j.jhepr.2023.100871
|
5 |
Tomas Koller, Petra Vrbova, Natalia Kubanek, Daniela Zilincanova, Svetlana Adamcova Selcanova, Daniel Jan Havaj, Lubomir Skladany. Assessment of intestinal inflammation via fecal calprotectin for early prediction of adverse outcomes in advanced chronic liver disease. United European Gastroenterology Journal 2024; doi: 10.1002/ueg2.12633
|
6 |
Camila Marques de Alcântara Barreto, Eliane Almeida do Valle, Jessica Pronestino de Lima Moreira, Katia Farias e Silva, Siane Lopes Bittencourt Rosas, Patrícia Teixeira Santana, Ana Maria Pittella, Gustavo Pereira, Flavia Ferreira Fernandes, Renata de Mello Perez, Heitor Siffert Pereira de Souza. Gut-related molecules as potential biomarkers in patients with decompensated cirrhosis. Annals of Hepatology 2025; 30(1): 101567 doi: 10.1016/j.aohep.2024.101567
|